Category Archives: Claim Construction

IPR obviousness and non-obviousness findings affirmed (e.g,. the Board “explained why”)

Boston Scientific Neuromodulation Corp. v. Nevro Corp., Andrei Iancu (USPTO, intervenor) Docket No. 2019-1582, -1635 (IPR2017-01812, -01920) LOURIE, MOORE, O’MALLEY May 29, 2020 Non-precedential Brief Summary: Board IPR final written decisions finding certain of Boston’s claim unpatentable for obviousness and … Continue reading

Posted in Claim Construction, Inter Parties Review (IPR), IPR, Obviousness | Leave a comment

IPR obviousness findings affirmed except for one claim that “describes a stand-alone alternative” to means-plus-function limitation

Cochlear Bone Anchored Solutions AB v. Oticon Medical AB, et al. Docket No. 2019-1105, -1106 (IPR2017-01018, -01019) NEWMAN, O’MALLEY, TARANTO May 15, 2020 Brief Summary: Board IPR obviousness findings affirmed, while its analysis of one means-plus-function claim vacated and remanded. … Continue reading

Posted in Claim Construction, Inter Parties Review (IPR), IPR, Means-plus-function, Obviousness | Leave a comment

Board IPR FWD finding BSN’s claims obvious affirmed, claim construction arguments waived

Boston Scientific Neuromodulation Corp. v. Nevro Corp., USPTO as Intervenor Docket No. 2019-1584 (IPR2017-01899) LOURIE, MOORE, O’MALLEY May 18, 2020 Non-precedential Brief Summary: Board IPR FWD finding BSN’s claims obvious affirmed (e.g., BSN “waived any claim construction argument…by failing to … Continue reading

Posted in Claim Construction, Inter Parties Review (IPR), IPR, Obviousness | Leave a comment

DC non-infringement decision affirmed due to disclosure-dedication doctrine

Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC Docket No. 2019-1924 O’MALLEY, REYNA, CHEN May 8, 2020 Brief Summary: DC finding of no infringement under DOE based on disclosure-dedication doctrine affirmed. Summary: Eagle appealed DC judgment of non-infringement of US Pat. … Continue reading

Posted in Claim Construction, Doctrine of equivalents, Infringement | Leave a comment

IPR decision of no obviousness vacated and remanded; Grit found to have Article III standing based on previously dismissed (without prejudice) litigation

Grit Energy Solutions, LLC v. Oren Technologies, LLC Docket No. 2019-1063 (IPR2017-00768) PROST, NEWMAN, WALLACH April 30, 2020 Brief Summary: PTAB IPR decision of no obviousness vacated and remanded; Grit found to have Article III standing based on previously dismissed … Continue reading

Posted in Article III disputes, Claim Construction, Inter Parties Review (IPR), IPR, Obviousness | Leave a comment

Claim construction reversed since DC excluded preferred embodiment and “‘equivalent’ does not require mathematical precision”

Rembrandt Diagnostics, LP v. Alere, Inc. et al. Docket No. 2019-1595, -1648 WALLACH, MAYER, STOLL April 10, 2020 Non-precedential Brief Summary: FC panel reverses DC claim construction (e.g., cannot exclude preferred embodiment, “‘equivalent’ does not require mathematical precision”). Summary: Rembrandt … Continue reading

Posted in Claim Construction, Prosecution History Estoppel | Leave a comment

IPR claim construction of “effective amount” based on prosecution history and obviousness conclusions affirmed; no abuse of discretion in Board’s denial to amend after modifying institution decision

Genentech, Inc. v. Andrei Iancu (USPTO) Docket No. 2019-1263, -1265, -1267, -1270 IPRs 2017-00731, -01121, -02063, -00737, -01122, -01960 LOURIE, MOORE, WALLACH March 26, 2020 Non-Precedential Brief Summary: Board’s claim construction (e.g., “effective amount”), obviousness conclusion and denial of amendment … Continue reading

Posted in Claim Construction, Inter Parties Review (IPR), IPR, Obviousness, Prosecution History Estoppel | Leave a comment

Rejected claim construction proposal during IPR was not prosecution history estoppel, FC affirms infringement under DOE; second infringement decision reversed

Galderma Labs., Nestle Skin Health S.A. et al. v. Amneal Pharm. LLC et al. Docket No. 2019-1021 LOURIE, MOORE, STOLL March 25, 2020 Non-Precedential Brief Summary: DC finding of infringement of certain claims affirmed as statements made in related IPR … Continue reading

Posted in Claim Construction, Doctrine of equivalents, Infringement, Inter Parties Review (IPR), IPR, Prosecution History Estoppel, Uncategorized | Leave a comment

IPR decision of obviousness of method of treatment claim reversed for erroneous claim construction

Kaken Pharm. Co., Inc., Bausch Health Cos. Inc. v. USPTO Docket No. 2018-2232 (IPR2017-00190, -01429) NEWMAN, O’MALLEY, TARANTO March 13, 2020 Brief Summary: IPR obviousness decision reversed based on erroneous claim construction in method of treatment claim. Summary: Kaken appealed … Continue reading

Posted in Claim Construction, Inter Parties Review (IPR), IPR, Obviousness, Uncategorized | Leave a comment

Board IPR decision of no obviousness reversed as claim construction excluded preferred embodiment

Uber Technologies, Inc. v. X One, Inc. Docket No. 2019-1165 (IPR2017-01264) PROST, DYK, WALLACH March 3, 2020 Non-precedential Brief Summary: Board IPR decision of no obviousness of certain mapping-related claims reversed as claim construction would exclude the preferred embodiment; obviousness … Continue reading

Posted in Claim Construction, Inter Parties Review (IPR), IPR, Obviousness, Uncategorized | Leave a comment